Clinical trial
A Phase 2A, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ES-481 in Adult Patients With Drug Resistant Epilepsy
NCT04714996 is registered in ClinicalTrials.gov with ES Therapeutics Australia Pty Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2A, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ES-481 in Adult Patients With Drug Resistant Epilepsy
- Lead sponsor
- ES Therapeutics Australia Pty Ltd
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- October 30, 2020
- Completion date
- December 31, 2023
- Enrollment
- 24 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.